Bill Text: TN HB1208 | 2019-2020 | 111th General Assembly | Draft

Bill Title: As introduced, requires certain insurers that provide major medical insurance coverage to make available on an optional basis as part of or as an endorsement to each policy that is issued, delivered, issued for delivery, or renewed in this state on or after January 1, 2020, coverage for stem cell therapy. - Amends TCA Title 8; Title 56 and Title 71.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2019-02-13 - Assigned to s/c Life & Health Insurance Subcommittee [HB1208 Detail]

Download: Tennessee-2019-HB1208-Draft.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.